Cardiac manifestations of parasitic infections part 2: Parasitic myocardial disease

Clinical Cardiology

Volumn 30, Issue 5, 2007, Pages 218-222

  Franco Paredes, Carlos ^a,c,d   Rouphael, Nadine ^a   Méndez, José ^a   Folch, Erik ^a,e   Rodríguez Morales, Alfonso J ^b   Santos, José Ignacio ^c   Hurst, J W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD DE LOS ANDES   (Venezuela)

^c HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^d Division of Infectious Diseases   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chagas disease; Heart; Myocardium; Parasites; Pericardium

Indexed keywords

AFRICAN TRYPANOSOMIASIS; AMASTIGOTE; ARTICLE; CHAGAS DISEASE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; HEART ARRHYTHMIA; HEART FAILURE; HIGH RISK PATIENT; HUMAN; MYOCARDIAL DISEASE; NONHUMAN; PARASITOSIS; PATHOGENESIS; QRS COMPLEX; SYMPTOMATOLOGY; TRICHINELLA SPIRALIS; TRICHINOSIS; TRYPANOSOMA CRUZI;

CARDIOMYOPATHIES; CHAGAS CARDIOMYOPATHY; HUMANS; PROTOZOAN INFECTIONS; TOXOPLASMOSIS; TRICHINOSIS; TRYPANOSOMIASIS, AFRICAN;

EID: 34249029266     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20091     Document Type: Article

References (48)

1. Centers for Disease Control and Prevention. Treating opportunistic infections among HIV-1 Adults and Adolescents. MMWR 2004;53(RR15):1-112
2. Matturri L, Quattrone P, Varesi C, Rossi L: Cardiac toxoplasmosis in pathology of acquired immunodeficiency syndrome. Panminerva Med 1990;32(4):194-196
3. Hofman P, Drici MD, Gibelin P, Michiels JF, Thyss A: Prevalence of toxoplasma myocarditis in patients with the acquired immunodeficiency syndrome. Br Heart J 1993;70(4):376-381
4. Ryning FW, McLeod R, Maddox JC, Hunt S, Remington JS: Probable transmission of Toxoplasma gondii by organ transplantation. Ann Intern Med 1979;90(1):47-49
5. Gallino A, Maggiorini M, Kiowski W, Martin X, Wunderli W, et al.: Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol Infect Dis 1996;15(5):389-393
6. Mayes JT, O'Connor BJ, Avery R, Castellani W, Carey W: Transmission of Toxoplasma gondii infection by liver transplantation Clin Infect Dis 1995;21(3):511-515
7. Reynolds ES, Walls KW, Pfeiffer RI: Generalized toxoplasmosis following renal transplantation. Report of a case. Arch Intern Med 1966;118(4):401-405
8. Slavin MA, Meyers JD, Remington JS, Hackman RC: Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplant 1994;13(5):549-557
9. Mary AS, Hamilton M: Ventricular tachycardia in a patient with toxoplasmosis. Br Heart J 1973;35(3):349-352
10. Politi Okoshi M, Rubens Montenegro M: Pathology of the heart in AIDS. Study of 73 consecutive necropsies. Arq Bras Cardiol 1996;66(3):129-133
11. Wreghitt TG, Gray JJ, Pavel P, Balfour A, Fabbri A, et al.: Efficacy of pyrimethamine for the prevention of donor-acquired Toxoplasma gondii infection in heart and heart-lung transplant patients. Transpl Int 1992;5(4):197-200
12. Hoffman P, Bernard E, Michiels JF, Thyss A, Le Fichoux Y, et al.: Extracerebral toxoplasmosis in the acquired immunodeficiency syndrome (AIDS). Pathol Res Pract 1993;189(8):894-901
13. Sahasrabudhe NS, Jadhav MV, Deshmukh SD, Holla VV: Pathology of Toxoplasma myocarditis in acquired immunodeficiency syndrome. Indian J Pathol Microbiol 2003;46(4):649-651
14. Wagner FM, Reichenspurner H, Uberfuhr P, Weiss M, Fingerle V, et al.: Toxoplasmosis after heart transplantation: diagnosis by endomyocardial biopsy. J Heart Lung Transplant 1994;13(5):916-918
15. Moorhead A, Grunenwald PE, Dietz VJ, Schantz PM: Trichinellosis in the United States, 1991-1996: declining but not gone. Am J Trop Med Hyg 1999;60(1):66-69
16. Lazarevic AM, Neskovic AN, Goronja M, Golubovic S, Komic J, et al.: Low incidence of cardiac abnormalities in treated trichinosis: a prospective study of 62 patients from a single-source outbreak. Am J Med 1999;107(1):18-23
17. Andy JJ, O'Connell JP, Daddario RC, Roberts WC: Trichinosis causing extensive ventricular mural endocarditis with superimposed thrombosis. Evidence that severe eosinophilia damages endocardium Am J Med 1977;63(5):824-829
18. Kirschberg GJ: Trichinosis presenting as acute myocardial infarction. Can Med Assoc J 1972;106(8):898-899
19. Compton SJ, Celum CL, Lee C, Thompson D, Sumi SM, et al.: Trichinosis with ventilatory failure and persistent myocarditis. Clin Infect Dis 1993;16(4):500-504
20. Siwak E, Dron D, Pancewicz S, Zajkowska J, Snarska I, et al.: Changes in ECG examination of patients with trichinosis. Wiad Lek 1994;47(13-14):499-502
21. Urbina JA, Docampo R: Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol 2003;19(11):495-501
22. Punukollu G, Gowda RM, Khan IA: Early twentieth century descriptions of the Chagas heart disease. Int J Cardiol 2004;95:347-349
23. de Faria JB, Alves G: Transmission of Chagas' disease through cadaveric renal transplantation. Transplantation 1993;56(6): 1583-1584
24. Gurtler RE, Segura EL, Cohen JE: Congenital transmission of Trypanosoma cruzi infection in Argentina. Emerg Infect Dis 2003;9(1):29-32
25. Ferreira MS, Nishioka Sde A, Silvestre MT, Borges AS, Nunes-Araujo FR, et al.: Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature. Clin Infect Dis 1997;25:1397-1400
26. Barcan L, Lunao O, Clara L, Sinagra A, Valledor A, et al.: Transmission of T. Cruzi infection via liver transplantation to a non reactive recipient for Chagas' disease. Liver Transpl 2005;11(9):1112-1116
27. ProMED-mail. Trypanosomiasis, foodborne - Brazil (Santa Catarina) ProMED-mail 2005; 24 Mar: 20050324.0847. 〈http://www. promedmail.org〉. Accessed December 31, 2006
28. Machado FS, Koyama NS, Carregaro V, Ferreira BR, Milanezi CM, et al: CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi. J Infect Dis 2005;191(4):627-636
29. Añez N, Carrasco H, Parada H, Crisante G, Rojas A, et al.: Myocardial parasite persistence in chronic chagasic patients. Am J Trop Med Hyg 1999;60(5):726-732
30. Elias MC, Vargas N, Tomazi L, Pedroso A, Zingales B, et al: Comparative analysis of genomic sequences suggests that Trypanosoma cruzi CL Brenner contains two sets of non-intercalated repeats of satellite DNA that correspond to T. cruzi I and T. cruzi II types. Mol Biochem Parasitol 2005;140:221-227
31. Lages-Sila E, Crema E, Ramirez LE, Macedo AM, Pena SD, et al.: Relationship between Trypanosoma cruzi and human chagasic megaesophagus: blood and tissue parasitism. Am J Trop Med Hyg 2001;65(5):435-441
32. Pinto Dias JC: The treatment of Chagas disease (South American trypanosomiasis). Ann Intern Med 2006;144(10):772-774
33. Rassi A Jr, Rassi SG, Rassi A: Sudden death in Chagas' disease. Arq Bras Cardiol 2001;76(1):75-96
34. Samuel J, Oliveira M, Correa De Araujo RR, Navarro MA, Mucillo G: Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease. Am J Cardiol 1983;52(1):147-151
35. Garzon SA, Lorga AM, Nicolau JC: Electrocardiography in Chagas' heart disease. Sao Paulo Med J 1995;113(2):802-813
36. Scanavacca M, Sosa E: Electrophysiologic study in chronic Chagas' heart disease. Sao Paulo Med J 1995;113(2):841-850
37. Ferreira AW, de Avila SD: Laboratory diagnosis of Chagas' heart disease. Sao Paulo Med J 1995;113(2):767-771
38. Ribeiro AL, dos Reis AM, Barros MV, de Sousa MR, Rocha AL, et al: Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease. Lancet 2002;360(9331):461-462
39. de Andrade AL, Zicker F, de Oliveira RM, Almeida Silva S, Luquetti A, et al: Randomised trial of efficacy of bensnidazole in treatment of early Trypanosoma cruzi infection. Lancet 1996;348:1407-1413
40. Villar JC, Marin-Neto JA, Ebrahim S, Yusuf S. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection. Cochrane Database Syst Rev 2002;1;CD003463
41. Bocchi EA, Fiorelli A: The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology. Ann Thorac Surg 2001;71:1833
42. Moreira LF, Seferian P, Bocchi EA, Pego-Fernandes PM, Stolf NA, et al.: Survival improvement with dynamic cardiomyoplasty in patients with dilated cardiomyopathy. Circulation 1991;84(5 Suppl 1):III296-III302
43. Rodriguez H, Munoz M, Llamas G, Iturralde P, Medeiros A, et al.: Automatic, implantable cardioverter-defibrillator in a patient with chronic Chagas cardiopathy and sustained ventricular tachycardia. Arch Inst Cardiol Mex 1998;68(5):391-399
44. Sinha A, Grace C, Alston WK, Westenfeld F, Maguire JH: African trypanosomiasis in two travelers from the United States. Clin Infect Dis 1999;29:840
45. Moore A: Prospects for improving African trypanosomiasis chemotherapy. J Infect Dis 2005;191:1793-1796
46. Schmid C, Richer M, Bilenge CMM, Josenando T, Chappuis F, et al.: Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II). J Infect Dis 2005;191:1922-1931
47. Bertrand E: Cardiac involvement in human African trypanosomiasis. Med Trop (Mars) 1987;47(1):91-93
48. Jones IG, Lowenthal MN, Buyst H: Electrocardiographic changes in African trypanosomiasis caused by Trypanosoma brucei rhodesiense. Trans R Soc Trop Med Hyg 1975;69(4):388-395